Looking at readmissions for congestive heart failure, we realized that the majority of our patients were being readmitted because of care coordination and social determinants of health, explained Susan Mani, MD, vice president of Clinical Transformation and Ambulatory Quality at LifeBridge Health.
Looking at readmissions for congestive heart failure, we realized that the majority of our patients were being readmitted because of care coordination and social determinants of health, explained Susan Mani, MD, vice president of Clinical Transformation and Ambulatory Quality at LifeBridge Health.
Transcript
How did LifeBridge Health initially get involved with social determinants of health?
One of the things that we had to address for readmission was to really try to understand why patients were getting readmitted in the first place. When we took a look at our data, congestive heart failure patients had a particularly high rate of readmission, which really mimics what’s happening in the national sphere, as well. As we delved deep into each of our patients for their readmissions, both by interviewing them as well as looking for reason of readmission from a clinical review, what we were finding is most patients were not being readmitted because of a clinical issue that didn’t happen when they were first hospitalized. What we were finding is the vast majority of our patients were being readmitted because they really didn’t have access to care coordination, they really had issues with social determinants of health. So, that was a big aha moment for us as a health system to say, "If we don’t address this particular arena, we really aren’t going to be successful at preventing readmissions."
So, with that, and speaking with our patients and speaking with our clinicians, we really had to start thinking about transportation needs, how are our patients going to get the medications they’re prescribed, how are they going to get the kinds of foods they need to prevent them from coming back into the hospital, how are they going to be able to coordinate with the 4 or 5 different physicians that they might have to see after being in the hospital? And, even, how are they doing to manage really from a psychosocial standpoint, because they are extremely fragile after a hospital discharge from a clinical standpoint, so we really need to think about them holistically.
NGS-Based Test Accurately Detects Post–Allo-HSCT Relapse in AML, MDS
February 21st 2025The next-generation sequencing (NGS)–based AlloHeme test accurately predicted relapse following allogeneic hematopoietic stem cell transplantation (allo-HSCT) in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).
Read More
CMS Medicare Final Rule: Advancing Benefits, Competition, and Consumer Protection
May 7th 2024On this episode of Managed Care Cast, we're talking with Karen Iapoce, senior director of government products and programs at ZeOmega, about the recent CMS final rule on Medicare Part D and Medicare Advantage.
Listen
“Expanding Access Isn’t Just About Fairness—It’s About Building Better Treatments for Everyone”
February 16th 2025Regina Barragan-Carrillo, MD, a postdoctoral fellow at City of Hope Comprehensive Cancer Center, discussed findings that show 76% of renal cell carcinoma trials take place in wealthy countries, amid news that clinical trial access for the world's poor may become even more challenging.
Read More
Amid Debate Over Diversity, RCC Trials Still Struggle to Reflect Patient Populations
February 16th 2025Abstracts presented at the American Society of Clinical Oncology Genitourinary Cancers Symposium reflect the ongoing challenge with enrolling diverse patient populations in trials, despite stated goals.
Read More